Profusa (PFSA) Other Non-Current Liabilities (2021 - 2026)
Profusa's (PFSA) quarterly Other Non-Current Liabilities came in at $11.4 million in Q1 2026, up 33332.88% year-on-year from N/an in Q1 2025, and down 7.43% quarter-over-quarter from $12.3 million in Q4 2025.
Profusa (PFSA) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Profusa's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 33332.88% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $11.4 million, a 33332.88% increase from a year earlier, with the FY2025 full-year figure at $12.3 million, up 452.15% from the prior year.
- Other Non-Current Liabilities declined to $11.4 million in Q1 2026 per PFSA's latest filing, from $12.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $18.8 million in Q3 2025 and bottomed at $31308.0 in Q2 2024.
- The 5-year median for Other Non-Current Liabilities is $652659.0 (2024), against an average of $4.2 million.
- Across the five-year window, Other Non-Current Liabilities tumbled 98.55% in 2023 and soared 55616.4% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $407131.0 in 2022, then sank by 83.76% to $66128.0 in 2023, then soared by 3278.3% to $2.2 million in 2024, then soared by 452.15% to $12.3 million in 2025, then slipped by 7.43% to $11.4 million in 2026.
- Per Business Quant, the three latest PFSA Other Non-Current Liabilities figures stand at $11.4 million (Q1 2026), $12.3 million (Q4 2025), and $18.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 12.34 Mn |
| Sep 30, 2025 | 18.80 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Mar 31, 2025 | 34,155.00 |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 652,659.00 |
| Jun 30, 2024 | 31,308.00 |
| Mar 31, 2024 | 300,837.00 |
| Dec 31, 2023 | 66,128.00 |
| Sep 30, 2023 | 293,900.00 |
| Jun 30, 2023 | 205,836.00 |
| Mar 31, 2023 | 48,386.00 |
| Dec 31, 2022 | 407,131.00 |
| Sep 30, 2022 | 969,125.00 |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 3.34 Mn |
| Dec 31, 2021 | 239,144.00 |